Creo Medical Group PLC (AIM:CREO) has launched SpydrBlade Flex in the UK and Europe, with St Mark’s Hospital in London as its first customer. The device enables minimally invasive treatment for colorectal cancer.
Poolbeg Pharma PLC (AIM:POLB) has secured a South Korean patent for its POLB 001 experimental flu treatment, protecting the drug until 2038. CEO Jeremy Skillington says the approval strengthens the company’s position as Phase 2 trials progress.
KEFI Gold and Copper PLC (AIM:KEFI, OTC:KFFLF)'s Saudi Arabia JV has won the Al Hajar North exploration licence, covering 910 square kilometres. A major Australian miner, Hancock Prospecting, is partnering on the licence, while bids for KEFI’s exit deal close on 31 March.
Bloomsbury Publishing PLC (LSE:BMY) expects another strong year, with results beating forecasts after a solid second half. Bestsellers from J.K. Rowling and Sarah J. Maas boosted its fiction division, while academic arm Bloomsbury Digital Resources continued to expand despite financial pressures in the sector.
